General
New $160,000 drug for multiple myeloma blood cancer to be added to PBS at a cost to patients of $480
More than 1,000 patients with an incurable type of blood cancer are expected to benefit from a “completely new” treatment that will be subsidised by the Federal Government in the new year.
Key points:
- Multiple myeloma is a type of blood cancer that causes about 1,000 deaths in Australia each year
- The drug Darzalex works by binding to the cancerous cells and allowing them to be destroyed
- Myeloma Australia’s chief executive says the drug getting listed on the PBS is “heart-lifting” news
Darzalex, which will be listed on the Pharmaceutical Benefits Scheme (PBS) from January 1, is a medicine used to treat multiple myeloma, a cancer that causes cancerous plasma cells to accumulate in bone marrow and crowd out healthy blood cells.
An estimated…
Continue Reading
-
General13 hours agoAlice Springs Beanie Festival draws a crowd with 7,000 woolly creations on display
-
Noosa News17 hours agoBrisbane’s abandoned 2032 Olympic Games
-
Noosa News13 hours agoParamedic who rescued farmer trapped in grain silo receives highest honour
-
Noosa News17 hours agoNoosa councillor: ‘Why I couldn’t support foreshore plan’